Show simple item record

Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

dc.contributor.authorRizzardini, G
dc.contributor.authorOverton, ET
dc.contributor.authorOrkin, C
dc.contributor.authorSwindells, S
dc.contributor.authorArasteh, K
dc.contributor.authorGorgolas Hernandez-Mora, M
dc.contributor.authorPokrovsky, V
dc.contributor.authorGirard, P-M
dc.contributor.authorOka, S
dc.contributor.authorAndrade-Villanueva, JF
dc.contributor.authorRichmond, GJ
dc.contributor.authorBaumgarten, A
dc.contributor.authorMasia, M
dc.contributor.authorLatiff, G
dc.contributor.authorGriffith, S
dc.contributor.authorHarrington, CM
dc.contributor.authorHudson, KJ
dc.contributor.authorSt Clair, M
dc.contributor.authorTalarico, CL
dc.contributor.authorPatel, P
dc.contributor.authorCutrell, A
dc.contributor.authorVan Eygen, V
dc.contributor.authorD'Amico, R
dc.contributor.authorMrus, JM
dc.contributor.authorWu, S
dc.contributor.authorFord, SL
dc.contributor.authorChow, K
dc.contributor.authorRoberts, J
dc.contributor.authorWills, A
dc.contributor.authorWalters, N
dc.contributor.authorVanveggel, S
dc.contributor.authorVan Solingen-Ristea, R
dc.contributor.authorCrauwels, H
dc.contributor.authorSmith, KY
dc.contributor.authorSpreen, WR
dc.contributor.authorMargolis, DA
dc.date.accessioned2021-03-31T08:58:31Z
dc.date.available2021-03-31T08:58:31Z
dc.date.issued2020-12-01
dc.identifier.issn1525-4135
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/70981
dc.format.extent498 - 506
dc.relation.ispartofJAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectlong-actingen_US
dc.subjectantiretroviral therapyen_US
dc.subjectinjectableen_US
dc.subjectcabotegraviren_US
dc.subjectrilpivirineen_US
dc.subjectHIVen_US
dc.titleLong-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trialsen_US
dc.typeArticleen_US
dc.identifier.doi10.1097/QAI.0000000000002466
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000587800200022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue4en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume85en_US


Files in this item

Thumbnail
Name:
Orkin Long-Acting Injectable ...
Size:
363.0Kb
Format:
application/
Description:
Published version
View/Open
Thumbnail
Name:
license_rdf
Size:
811bytes
Format:
application/rdf+xml
View/Open

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States